Protective CD8+ T cell responses against the pre-erythrocytic stages of malaria parasites: an overview
AUTOR(ES)
Oliveira-Ferreira, J, Daniel-Ribeiro, CT
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2001-02
RESUMO
CD8+ T cells have been implicated as critical effector cells in protection against the pre-erythrocytic stage of malaria in mice and humans following irradiated sporozoite immunization. Immunization experiments in animal models by several investigators have suggested different strategies for vaccination against malaria and many of the targets from liver stage malaria antigens have been shown to be immunogenic and to protect mice from the sporozoite challenge. Several prime/boost protocols with replicating vectors, such as vaccinia/influenza, with non-replicating vectors, such as recombinant particles derived from yeast transposon (Ty-particles) and modified vaccinia virus Ankara, and DNA, significantly enhanced CD8+ T cell immunogenicity and also the protective efficacy against the circumsporosoite protein of Plasmodium berghei and P. yeti. Based on these experimental results the development of a CD8+ T cell inducing vaccine has moved forward from epitope identification to planning stages of safety and immunogenicity trials of candidate vaccines.
Documentos Relacionados
- Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development
- Expansion of Protective CD8+ T-Cell Responses Driven by Recombinant Cytomegaloviruses
- Short-term antigen presentation and single clonal burst limit the magnitude of the CD8+ T cell responses to malaria liver stages
- γδ T Cells Are a Component of Early Immunity against Preerythrocytic Malaria Parasites
- Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.